65 results
DEFA14A
CRNX
Crinetics Pharmaceuticals Inc
25 Apr 24
Additional proxy soliciting materials
4:48pm
Materials
Soliciting Material under §240.14a-12
Crinetics Pharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
Crinetics Pharmaceuticals C/O
D
CRNX
Crinetics Pharmaceuticals Inc
11 Mar 24
$350.00 mm in equity, sold $350.00 mm, 36 investors
4:15pm
of this Form D, States cannot
routinely require offering materials under this undertaking or otherwise and can require offering materials only
8-K
EX-10.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
expenditures relating to any Environmental Laws.
2.27 Hazardous Materials. There has been no storage, generation, transportation, use, handling … , treatment, Release or threat of Release of Hazardous Materials by, relating to or caused by the Company or any of its subsidiaries (or, to the knowledge
8-K
EX-3.1
bi7q1lqa bplnnw31
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:35pm
8-K
EX-1.1
5e7o9gr
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
DEFA14A
dk862
27 Apr 23
Additional proxy soliciting materials
4:56pm
DEFA14A
x9ry3pkl89p0x81xi8
28 Apr 22
Additional proxy soliciting materials
4:58pm